Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1553531
PUBLISHER: Grand View Research | PRODUCT CODE: 1553531
UK Veterinary Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceutical), By Animal Type, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2024 - 2030
PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
UK Veterinary Medicine Market Growth & Trends:
The UK veterinary medicine market size is anticipated to reach USD 4.6 billion by 2030 and is anticipated to grow at a CAGR of 7.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the novel product development in veterinary medicine, the rise in livestock population and increasing pet ownership rates, and the increasing government initiatives to spread awareness about animal health.
There is an increasing trend of pet adoption in the country, particularly influenced by the increasing ownership of smaller pets. According to the UK Pet Food 2024 stats, the pet dog population is estimated to be around 13.5 million, which accounts for around 36% of the households in the country owning a dog. Similarly, the pet cat population is estimated to be around 12.5 million, which accounts for around 29% of the households in the country owning a cat. This surge in pet ownership has led to greater consumer spending on veterinary medicines as pet owners are increasingly prioritizing their pets' health, resulting in higher expenditures on veterinary care, medications, and preventive treatments. As pet owners become more aware of the long-term health implications and necessary care for their pets, the demand for veterinary medicine in the country is further anticipated to increase.
In addition, the increasing efforts by government and private bodies through various partnerships and initiatives to increase awareness about animal health among pet and cattle owners are further contributing to the market growth. For instance, The Animal Health and Welfare Pathway, launched in 2023, aims to enhance farm animal health and welfare in the UK through collaboration among farmers, veterinarians, and the industry. This initiative is part of the Agricultural Transition Plan, focusing on improving biosecurity, tackling antimicrobial resistance, and reducing greenhouse gas emissions from livestock.
Financial support for farmers is one of the major focuses of the pathway, offering funding for veterinary consultations, capital investments, and disease control programs. This includes grants for infrastructure improvements and initiatives to enhance stockmanship through training. The pathway also aims to stimulate market demand for higher welfare products by improving transparency and ensuring fair pricing for farmers.
Moreover, zoonotic diseases, which can be transmitted from animals to humans, have gained significant attention due to their potential impact on public health. This awareness drives pet owners and livestock farmers to seek preventive care and vaccinations for their animals, thereby boosting the demand for veterinary medication. Similarly, in agriculture, changing practices aimed at improving animal welfare and productivity are driving demand for veterinary interventions as farmers are increasingly adopting biosecurity measures to prevent disease outbreaks within livestock populations, thereby contributing to segment growth.
UK Veterinary Medicine Market Report Highlights:
- Based on product, the pharmaceutical segment accounted for the largest revenue share of 67.7% in 2023 as the increasing prevalence of diseases in both companion and production animals has heightened the demand for effective veterinary pharmaceuticals.
- The biologics segment is expected to witness the fastest CAGR in the market owing to the increasing awareness among pet owners and livestock farmers about the importance of preventive healthcare.
- Based on animal type, the production animal segment dominated the market with the largest revenue share in 2023 owing to the increasing demand for high-quality meat, milk, and other animal products, which drives farmers to invest in advanced veterinary care to ensure optimal health and productivity of their livestock.
- The companion animal segment is expected to witness the fastest growth over the forecast period as there is an increasing demand for innovative veterinary care that prioritizes pet health and well-being.
- Based on route of administration, the injectable segment dominated the market owing to their several key advantages such as significantly faster results, which is critical in treating acute conditions and managing diseases in animals
- Based on distribution channel, the veterinary hospitals and clinics segment dominated the market as these facilities serve as primary points for the administration of vet medicines such as biologics, including vaccines and monoclonal antibodies, which are critical for preventing and treating diseases in animals
- In September 2022, Boehringer Ingelheim launched Fencovis, a new vaccine aimed at preventing calf scour caused by rotavirus, bovine coronavirus, and E. coli F5 (K99), with availability in the UK before the end of the year. This vaccine is designed for pregnant heifers and cows to stimulate antibody development, enhancing passive immunity in calves. Fencovis has shown effectiveness in preventing diarrhea and reducing viral shedding in infected calves.
Product Code: GVR-4-68040-422-7
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Product Segment
- 1.2.2. Animal Type Segment
- 1.2.3. Route of Administration Segment
- 1.2.4. Distribution Channel Segment
- 1.3. Information analysis
- 1.3.1. Market formulation & data visualization
- 1.4. Data validation & publishing
- 1.5. Information Procurement
- 1.5.1. Primary Research
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Total Market: CAGR Calculation
- 1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Insights Landscape
Chapter 3. UK veterinary medicine Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rise in livestock population and increasing pet ownership rates
- 3.2.1.2. Novel product development in veterinary medicine
- 3.2.1.3. Increasing prevalence of animal diseases
- 3.2.1.4. Increasing public & private investment
- 3.2.2. Market restraint analysis
- 3.2.2.1. Regulatory Challenges
- 3.2.1. Market driver analysis
- 3.3. UK Veterinary Medicine Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. UK Veterinary Medicine Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. UK Veterinary Medicine Market Product Movement Analysis
- 4.3. UK Veterinary Medicine Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Biologics
- 4.4.1. Biologics market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Vaccines
- 4.4.2.1. Vaccines market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.2. Modified/ Attenuated live
- 4.4.2.2.1. Modified/ Attenuated live market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.3. Inactivated
- 4.4.2.3.1. Inactivated market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.4. Other vaccines
- 4.4.2.4.1. Other vaccines market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. Other biologics
- 4.4.3.1. Other biologics market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Pharmaceuticals
- 4.5.1. Pharmaceuticals market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2. Parasiticides
- 4.5.2.1. Parasiticides market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.3. Anti-infectives
- 4.5.3.1. Anti-infectives market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.4. Anti-inflammatory
- 4.5.4.1. Anti-inflammatory market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.5. Analgesics
- 4.5.5.1. Analgesics market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.6. Others
- 4.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Medicated feed additives
- 4.6.1. Medicated feed additives market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. UK Veterinary Medicine Market: Animal Type Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. UK Veterinary Medicine Market Animal Type Movement Analysis
- 5.3. UK Veterinary Medicine Materials Market Size & Trend Analysis, by Animal Type, 2018 to 2030 (USD Million)
- 5.4. Production animals
- 5.4.1. Production animals market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Poultry
- 5.4.2.1. Poultry market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Pigs
- 5.4.3.1. Pigs market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Cattle
- 5.4.4.1. Cattle market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.5. Sheep & goats
- 5.4.5.1. Sheep & goats market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.6. Others
- 5.4.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Companion animals
- 5.5.1. Companion animals market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.2. Dogs
- 5.5.2.1. Dogs market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.3. Cats
- 5.5.3.1. Cats market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.4. Horses
- 5.5.4.1. Horses market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.5. Others
- 5.5.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. UK Veterinary Medicine Materials Market: Route of Administration Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. UK Veterinary Medicine Market Route of Administration Movement Analysis
- 6.3. UK Veterinary Medicine Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
- 6.4. Oral
- 6.4.1. Oral market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Injectable
- 6.5.1. Injectable market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Topical
- 6.6.1. Topical market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7. Other routes
- 6.7.1. Other routes market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. UK Veterinary Medicine Market: Distribution Channel Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. UK Veterinary Medicine Market Distribution Channel Movement Analysis
- 7.3. UK Veterinary Medicine Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
- 7.4. Veterinary hospitals & clinics
- 7.4.1. Veterinary hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5. E-commerce
- 7.5.1. E-commerce market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Offline retail stores
- 7.6.1. Offline retail stores market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. Others
- 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company/Competition Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2023
- 8.4. Company Profiles/Listing
- 8.4.1. Boehringer Ingelheim International GmbH.
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Norbrook
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. Merck & Co., Inc.
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Elanco
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Bimeda, Inc.
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. Zoetis UK Limited.
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. Ceva
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. BioZyme, Inc.
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Hill's Pet Nutrition, Inc.
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. Decra
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product benchmarking
- 8.4.10.4. Strategic initiatives
- 8.4.1. Boehringer Ingelheim International GmbH.
Product Code: GVR-4-68040-422-7
List of Tables
- Table 1 List of abbreviation
- Table 2 UK Veterinary medicine market, by region, 2018 - 2030 (USD Million)
- Table 3 UK Veterinary medicine market, by product, 2018 - 2030 (USD Million)
- Table 4 UK Veterinary medicine market, by animal type, 2018 - 2030 (USD Million)
- Table 5 UK Veterinary medicine market, by route of administration, 2018 - 2030 (USD Million)
- Table 6 UK Veterinary medicine market, by distribution channel, 2018 - 2030 (USD Million)
- Table 7 Company Overview
- Table 8 Product Benchmarking
- Table 9 Financial Performance
- Table 10 Strategic Initiatives
List of Figures
- Fig. 1 Market research process
- Fig. 2 Data triangulation techniques
- Fig. 3 Market formulation & validation
- Fig. 4 UK veterinary medicine market: Market outlook
- Fig. 5 UK veterinary medicine market: Segment outlook
- Fig. 6 UK veterinary medicine market: Competitive landscape outlook
- Fig. 7 Parent market outlook
- Fig. 8 UK veterinary medicine market driver impact
- Fig. 9 UK veterinary medicine market restraint impact
- Fig. 10 UK veterinary medicine market: Product outlook and key takeaways
- Fig. 11 UK veterinary medicine market: Product movement analysis
- Fig. 12 Biologics market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 13 Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 14 Modified/ Attenuated live market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 15 Inactivated market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 16 Other vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 17 Other biologics market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 18 Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 19 Parasiticides market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 20 Anti-infectives market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 21 Anti-inflammatory market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 22 Analgesics market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 24 Medicated feed additives market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 25 UK veterinary medicine market: Animal Type outlook and key takeaways
- Fig. 26 UK veterinary medicine market: Animal Type movement analysis
- Fig. 27 Production animals market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 28 Poultry market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 29 Pigs market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 30 Cattle market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 31 Sheep & goats market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 33 Companion animals market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 34 Dogs market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 35 Cats market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 36 Horses market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 37 Others market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 38 UK veterinary medicine market: Route of Administration outlook and key takeaways
- Fig. 39 UK veterinary medicine market: Route of Administration movement analysis
- Fig. 40 Oral market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 41 Injectable market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 42 Topical market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 43 Other routes market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 44 UK veterinary medicine market: Distribution Channel outlook and key takeaways
- Fig. 45 UK veterinary medicine market: Distribution Channel movement analysis market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 46 Veterinary hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 47 E-commerce market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 48 Offline retail stores market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 49 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.